These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37609126)

  • 1. Maternal-fetal outcomes in patients with immune mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system.
    Hwang YM; Wei Q; Piekos SN; Vemuri B; Molani S; Mease P; Hood L; Hadlock JJ
    medRxiv; 2023 Aug; ():. PubMed ID: 37609126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal-fetal outcomes in patients with immune-mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system.
    Hwang YM; Wei Q; Piekos SN; Vemuri B; Molani S; Mease P; Hood L; Hadlock J
    EClinicalMedicine; 2024 Feb; 68():102435. PubMed ID: 38586478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.
    Wei Q; Mease PJ; Chiorean M; Iles-Shih L; Matos WF; Baumgartner A; Molani S; Hwang YM; Belhu B; Ralevski A; Hadlock J
    Lancet Digit Health; 2024 May; 6(5):e309-e322. PubMed ID: 38670740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system.
    Wei Q; Mease PJ; Chiorean M; Iles-Shih L; Matos WF; Baumgartner A; Molani S; Hwang YM; Belhu B; Ralevski A; Hadlock J
    medRxiv; 2023 Jun; ():. PubMed ID: 37425752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity-Matched Analysis of the Risk of Age-Related Macular Degeneration with Systemic Immune-Mediated Inflammatory Disease.
    Shukla P; Russell MW; Muste JC; Shaia JK; Kumar M; Nowacki AS; Hajj-Ali RA; Singh RP; Talcott KE
    Ophthalmol Retina; 2024 Aug; 8(8):778-785. PubMed ID: 38320691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
    Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
    Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases.
    N MS; Álvarez-Troncoso J; Robles-Marhuenda Á; De la Calle Fernández-Miranda M; Muner Hernando ML; Bartha JL
    J Autoimmun; 2024 Sep; 148():103301. PubMed ID: 39141986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
    Bellinger DL; Lorton D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
    Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
    J Rheumatol; 2022 May; 49(5):523-530. PubMed ID: 35105713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing.
    Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
    Arthritis Care Res (Hoboken); 2023 Feb; 75(2):317-325. PubMed ID: 34486829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
    Burisch J; Jess T; Egeberg A
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care.
    Syed U; Subramanian A; Wraith DC; Lord JM; McGee K; Ghokale K; Nirantharakumar K; Haroon S
    BMC Med; 2023 Sep; 21(1):363. PubMed ID: 37735654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease.
    Braithwaite T; Adderley NJ; Subramanian A; Galloway J; Kempen JH; Gokhale K; Cope AP; Dick AD; Nirantharakumar K; Denniston AK
    Arthritis Rheumatol; 2021 Jul; 73(7):1267-1276. PubMed ID: 33728815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes Following Acute Coronary Syndrome in Patients With and Without Rheumatic Immune-Mediated Inflammatory Diseases.
    Wassif H; Saad M; Desai R; Hajj-Ali RA; Menon V; Chaudhury P; Nakhla M; Puri R; Prasada S; Reed GW; Ziada K; Kapadia S; Desai M; Mentias A
    J Am Heart Assoc; 2022 Sep; 11(18):e026411. PubMed ID: 36102221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.
    Meserve J; Luo J; Zhu W; Veeravalli N; Bandoli G; Chambers CD; Singh AG; Boland BS; Sandborn WJ; Mahadevan U; Singh S
    Gastroenterology; 2021 Jul; 161(1):107-115.e3. PubMed ID: 33744307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in the immune-mediated inflammatory diseases compared with age-matched controls: Systematic review and meta-regression.
    Gwinnutt JM; Toyoda T; Barraclough M; Verstappen SMM; Hornberger M; MacGregor A
    Semin Arthritis Rheum; 2023 Feb; 58():152131. PubMed ID: 36527929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine metabolome profiling of immune-mediated inflammatory diseases.
    Alonso A; Julià A; Vinaixa M; Domènech E; Fernández-Nebro A; Cañete JD; Ferrándiz C; Tornero J; Gisbert JP; Nos P; Casbas AG; Puig L; González-Álvaro I; Pinto-Tasende JA; Blanco R; Rodríguez MA; Beltran A; Correig X; Marsal S;
    BMC Med; 2016 Sep; 14(1):133. PubMed ID: 27609333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secular trends of low birth weight, preterm birth, and small for gestational age in Shanghai from 2004 to 2020: an age-period-cohort analysis.
    Zhou R; Yu H; Qian N; Jin S; Cai R; Chen L; Wang C; Wu F
    BMC Pregnancy Childbirth; 2023 Jul; 23(1):540. PubMed ID: 37495942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of interpregnancy interval with adverse pregnancy outcomes according to the outcomes of the preceding pregnancy: a longitudinal study with 4.7 million live births from Brazil.
    Tedde JGG; Cerqueira-Silva T; Lagrosa Garcia SA; Amira BV; Rodrigues LC; Barreto ML; Rocha AS; de Cássia Ribeiro-Silva R; Falcão IR; Paixao ES
    Lancet Reg Health Am; 2024 Feb; 30():100687. PubMed ID: 38332936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.